Key Points
Nandini Piramal, Chairperson, Piramal Pharma, says in the CDMO business services, service is a differentiator along with quality..
We have had our last five audits with the USFDA, and we have got EIRs for all of them and so, that is one of those things where quality, I think is a differentiator and it makes a difference when customers come to our plants, they talk to the people, not just regulatory audits..
We have a lot of customer audits, and they can see the difference...
There is a view that one of the businesses which is the consumer or OTC end of the business, right now does give you top line, but does not really contribute in margins so much..
Track latest market news, stock tips and expert advice on ETMarkets..
You might be interested in
AI is taking the world by storm: Popular AI growth stocks to add to watchlist
23, Jul, 23The Indian artificial intelligence sector could potentially produce the biggest wealth creators in the next few years. These five stocks should be on every investor’s radar.
Anant Maheshwari, ex-Microsoft India head, appointed Honeywell high growth region President and CEO
04, Aug, 23In his new role, Maheshwari will lead business growth across Honeywell’s geographies in China, India, Southeast Asia, Central and Eastern Europe, the Middle East, Central Asia, Africa and Latin America.
Stocks in news: LIC, Granules, Siemens, CAMS, Hero MotoCorp, GAIL
04, Dec, 23Granules India announced that the USFDA has approved its Abbreviated New Drug Application, filed by Granules Pharmaceuticals, a wholly owned foreign subsidiary of the company, for Sildenafil for Oral Suspension.
Having FOMO on largecaps? Sanjiv Bhasin picks 3 to bet on
05, Dec, 23“We have taken chips off the midcaps, we are putting them into largecaps. Three names, which I can suggest would be HDFC Life. Insurance stocks are hitting new highs. Second would be Godrej Properties. It is a proxy to gold and the stock is hitting all time highs. The third would be L&T Technologies. Presence in defence and allied areas makes it a very good choice.”
Unseasonal rains unfavorably impact Coca-Cola’s India business
26, Jul, 23India business was unfavorably impacted by unseasonable rain and cooler temperatures in the quarter. However, the growth outlook remains intact, James Quincey, chairman and CEO of The Coca-Cola Company said
Select midcap pharma, media & IT stocks poised to do well next 3-5 years: Varun Goel
01, Oct, 23“From a margin perspective, things are getting better and revenue growth should start accelerating from the third quarter onwards. Therefore, we believe that in a lot of the small cap and midcap names, there is an opportunity to do bottom-up stock picking and we remain quite constructive on selective names.”
Piramal Pharma allocates Rs 330 crore towards capex H2FY24
04, Dec, 23Firm targets Rs 1,000 crore growth in consumer health business
Cyient to focus actively on India: CEO Karthikeyan Natarajan
23, Apr, 23The Hyderabad-based company, which has a presence across 19 countries, is currently bullish on the sustainability business in India.
P&G can set up plants in India for exports: India MD & CEO Vaidyanathan
29, Jun, 23In an interview, L V Vaidyanathan, MD and CEO, P&G India said investments will “continue to come” to India as favourable demographics drive demand for its products